- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Sorafenib (Nexavar, BAY 43-9006)
Total 456 results
-
BayerCompletedNeoplasmsUnited States
-
BayerCompletedCarcinoma, Renal Cell | Carcinoma, Renal Cell (Advanced)Belgium
-
BayerCompleted
-
National Cancer Institute (NCI)NCIC Clinical Trials Group; Southwest Oncology Group; Cancer and Leukemia Group...CompletedClear Cell Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v7 | Stage II Renal Cell Cancer AJCC v7 | Stage I Renal Cell Cancer AJCC v6 and v7United States, Canada, Puerto Rico
-
BayerAmgenCompletedCarcinoma, Renal CellItaly, Spain, Canada, United States, Russian Federation, France, Australia, Chile, Germany, Hungary, Israel, United Kingdom, South Africa, Poland, Netherlands, Belgium, Ukraine, Argentina, Brazil
-
BayerAmgenCompletedCarcinoma, Renal CellUnited States, United Kingdom
-
BayerCompleted
-
BayerCompleted
-
Italian Trial in Medical OncologyCompletedHepatocellular CarcinomaItaly
-
BayerCompletedCarcinoma, HepatocellularBelgium, Italy, Spain, Canada, Switzerland, Germany, Greece, Russian Federation, France, United States, United Kingdom, Chile, New Zealand, Australia, Romania, Bulgaria, Croatia, Israel, Peru, Poland, Mexico, Brazil, Argentina
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedMetastatic Malignant Neoplasm | Advanced Malignant Neoplasm | Recurrent Malignant Neoplasm | Refractory Malignant Neoplasm | BRAF Gene MutationUnited States
-
BayerCompletedCarcinoma, HepatocellularBelgium, France, Spain, China, Hong Kong, United States, Canada, Switzerland, Germany, Portugal, Taiwan, Japan, Russian Federation, Singapore, Austria, United Kingdom, Korea, Republic of, Australia, New Zealand, Mexico, Brazil, Italy and more
-
BayerCompletedCarcinoma, HepatocellularBelgium, Israel, Italy, France, United States
-
BayerTerminatedCarcinoma, Renal CellUnited States
-
National Cancer Institute (NCI)M.D. Anderson Cancer CenterCompletedClear Cell Renal Cell Carcinoma | Recurrent Renal Cell Carcinoma | Stage IV Renal Cell CancerUnited States
-
NYU Langone HealthBayer; OSI PharmaceuticalsCompletedPancreatic CancerUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedAdult Glioblastoma | Adult Gliosarcoma | Recurrent Adult Brain NeoplasmUnited States
-
BayerWithdrawn
-
BayerCompletedCarcinoma, HepatocellularKorea, Republic of, Japan
-
SCRI Development Innovations, LLCBayerCompletedOvarian CancerUnited States
-
National Cancer Institute (NCI)Active, not recruitingAcute Myeloid Leukemia | Recurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Acute Myeloid Leukemia Post Cytotoxic TherapyUnited States
-
Indiana University School of MedicineAmgenCompletedPancreatic Cancer | Adenocarcinoma of the PancreasUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteBayer; Pediatric Cancer FoundationCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteBayerCompletedRectal CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteBayerTerminated
-
Masonic Cancer Center, University of MinnesotaCompletedSarcoma | Breast Cancer | Head and Neck Cancer | Colorectal Cancer | Pancreatic Cancer | Lung Cancer | Prostate Cancer | MesotheliomaUnited States
-
BayerTerminated
-
National Cancer Institute (NCI)CompletedFallopian Tube Cancer | Primary Peritoneal Cancer | Ovarian NeoplasmUnited States
-
BayerOnyx Therapeutics, Inc.CompletedBreast CancerSpain, Ireland, Japan, Russian Federation, United States, Australia, Austria, Czechia, Belgium, China, Germany, Hungary, Israel, South Africa, United Kingdom, France, Greece, Puerto Rico, Italy, Canada, Poland, Sweden, Argentina
-
University of Wisconsin, MadisonBayerCompletedCarcinoma, Non Small Cell LungUnited States
-
BayerCompletedThyroid NeoplasmsUnited States, Japan, Turkey, Russian Federation, India, Germany, France, Mexico, Philippines, Greece, Netherlands, Spain, Taiwan, Brazil, Egypt, Argentina, Algeria, Lebanon, Saudi Arabia
-
BayerCompletedCarcinoma, HepatocellularBelgium, France, Spain, Hong Kong, United States, Canada, Germany, Greece, New Zealand, Russian Federation, Australia, Taiwan, Austria, United Kingdom, China, Israel, Korea, Republic of, Bulgaria, Brazil, Poland, Italy, Colombia, South... and more
-
BayerAmgenCompletedMelanoma | CancerUnited States
-
BayerCompletedCarcinoma, Renal CellRussian Federation, France, United States, Germany, Poland, Ukraine, United Kingdom
-
National Cancer Institute (NCI)Completed
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Bayer; Genzyme, a Sanofi Company; Amgen; Georgia...CompletedLeukemia | Acute Myelogenous LeukemiaUnited States
-
Robin Kate KelleyBristol-Myers Squibb; BayerActive, not recruitingStage III Hepatocellular Carcinoma AJCC v8 | Stage IIIA Hepatocellular Carcinoma AJCC v8 | Stage IIIB Hepatocellular Carcinoma AJCC v7 | Stage IIIC Hepatocellular Carcinoma AJCC v7 | Stage IV Hepatocellular Carcinoma AJCC v8 | Stage IVA Hepatocellular Carcinoma AJCC v8 | Stage IVB Hepatocellular...United States
-
BayerCompletedCoronavirus Disease 2019 (COVID-19) | SARS-CoV-2 Infection | Malignant Solid TumorsUnited States
-
Emory UniversityOSI PharmaceuticalsTerminatedLiver CancerUnited States
-
Yabao Pharmaceutical GroupCompleted
-
National Cancer Institute (NCI)CompletedStage IV Skin Melanoma | Recurrent Melanoma | Stage IIIB Skin Melanoma | Stage IIIC Skin Melanoma | Mucosal Melanoma | Stage IIIA Skin MelanomaUnited States, Australia
-
University Health Network, TorontoCompletedNeuroendocrine TumorsCanada
-
National Cancer Institute (NCI)CompletedMetastatic Gastric Cancer | Adenocarcinoma of the Gastroesophageal Junction | Advanced Unresectable Gastric CancerUnited States
-
St. Jude Children's Research HospitalCompletedLeukemia | Refractory Solid TumorsUnited States
-
Leiden University Medical CenterCompletedThyroid CancerNetherlands